Insider Transactions Reported by 11 Insiders of OS Therapies Inc

Symbol
OSTX on NYSE
Location
Rockville, MD

Insiders trading volume in the past year

OS Therapies Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Shalom Auerbach Former 10% Owner $5,356,349 -$245,484 -4.4% 09 May 2025
Paul A. Romness President and CEO, Director $3,808,420 22 Jan 2026
Colin Goddard Director $1,516,581 31 Dec 2024
John Ciccio Director $701,985 22 Jan 2026
Theodore F. Search Director $701,985 22 Jan 2026
Robert Petit Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated. $308,000 22 Jan 2026
Christopher P. Acevedo Chief Financial Officer $168,437 22 Jan 2026
Avril McKean-Dieser Director $7,700 22 Jan 2026
Olivier Roger Jarry Director 22 Jan 2026
Karim Galzahr Director 22 Jan 2026
Joacim Borg Director 31 Jul 2024

Recent Insider Transactions by Companies or Individuals for OS Therapies Inc

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Avril McKean-Dieser OSTX Stock options (right to buy) Award 50,000 50,000 22 Jan 2026 Direct
Theodore F. Search OSTX Stock options (right to buy) Award 50,000 50,000 22 Jan 2026 Direct
John Ciccio OSTX Stock options (right to buy) Award 50,000 50,000 22 Jan 2026 Direct
Christopher P. Acevedo OSTX Stock options (right to buy) Award 100,000 100,000 22 Jan 2026 Direct
Robert Petit OSTX Stock options (right to buy) Award 100,000 100,000 22 Jan 2026 Direct
Paul A. Romness OSTX Stock options (right to buy) Award 1,000,000 1,000,000 22 Jan 2026 Direct
Olivier Roger Jarry OSTX Stock options (right to buy) Award 50,000 50,000 22 Jan 2026 Direct
Karim Galzahr OSTX Stock options (right to buy) Award 50,000 50,000 22 Jan 2026 Direct
Paul A. Romness OSTX Stock options (right to buy) Award 1,000,000 1,000,000 21 Oct 2025 Direct
Theodore F. Search OSTX Stock options (right to buy) Award 140,000 140,000 21 Oct 2025 Direct
Robert Petit OSTX Stock options (right to buy) Award 500,000 500,000 21 Oct 2025 Direct
Olivier Roger Jarry OSTX Stock options (right to buy) Award 140,000 140,000 21 Oct 2025 Direct
Karim Galzahr OSTX Stock options (right to buy) Award 140,000 140,000 21 Oct 2025 Direct
John Ciccio OSTX Stock options (right to buy) Award 140,000 140,000 21 Oct 2025 Direct
Christopher P. Acevedo OSTX Stock options (right to buy) Award 200,000 200,000 21 Oct 2025 Direct
Avril McKean-Dieser OSTX Stock options (right to buy) Award 140,000 140,000 21 Oct 2025 Direct
Shalom Auerbach OSTX Common Stock, par value $0.001 per share Sale -2.99% $163,918 $2.00 -82,000 2,664,199 07 May 2025 See Footnote
Shalom Auerbach OSTX Common Stock, par value $0.001 per share Sale -0.36% $13,900 $1.39 -10,000 2,746,199 10 Apr 2025 See Footnote
Shalom Auerbach OSTX Common Stock, par value $0.001 per share Sale -1.78% $67,666 $1.35 -50,012 2,756,199 09 Apr 2025 See Footnote
* An asterisk sign (*) next to the price indicates that the price is likely invalid.